JPMorgan cuts MercadoLibre stock price target on margin outlook

JPMorgan cut MercadoLibre’s price target to $1,900 from $2,100 and lowered 2026/2028 margin assumptions to 7.1% and 7.4%, implying EBIT cuts of 17% and 15% and EPS cuts of 20% and 10%. The firm sees a $340 million annualized EBIT hit from Brazilian take-rate changes, though revenue estimates were raised 5% and 9% for 2026 and 2028 as AI-driven and Brazil investments support growth. MercadoLibre also reported Q1 2026 revenue of $8.85 billion, topping expectations, but EPS of $8.23 missed consensus.

Analysis

MELI’s reset is less about a single-quarter margin miss and more about a deliberate re-acceleration strategy: management is choosing to defend market share in Brazil before monetization, which should pressure reported profitability for several quarters but widen the moat if it works. The key second-order effect is that lower take-rate promotions can force regional commerce peers to respond, compressing industry economics and making scale increasingly the only durable advantage. In that sense, the market may be underestimating how much of this spend is defensive capex disguised as margin sacrifice.

The more interesting signal is that revenue estimates are being lifted even as EBIT is cut, which implies the base case is shifting toward a longer runway of top-line compounding rather than near-term earnings power. If AI usage is genuinely improving conversion, pricing, and logistics efficiency, there is upside optionality in 2027-2028 margins that is not captured by the current 7%-7.5% comfort zone. The risk is that AI-driven expense savings are slower to show up than promotional costs, leaving consensus stuck in a low-confidence de-rating cycle.

Near term, the stock is vulnerable to another leg down if the next quarter confirms margin compression without a clear payback in GMV and engagement metrics. But at these levels, the asymmetry shifts: much of the bad news is now visible, while a re-rating only needs evidence that Brazil share gains are durable and that earnings revisions are bottoming. The contrarian view is that this may be a classic “buy the reinvestment” setup rather than a structural margin deterioration story, especially if growth reaccelerates into 2H26.

Key Decisions for Investors

• Hold a starter long in MELI with a 6-9 month horizon; size small and add only if the next print shows GMV/revenue acceleration with no further margin guide-down. Risk/reward: limited near-term multiple support, but 20-30% upside if the market starts capitalizing 2027 earnings instead of 2026.
• For traders, buy MELI downside hedges via 3-6 month put spreads into earnings or guidance updates; the setup favors volatility because revisions are still negative and the stock is near technical support. Use a defined-risk structure to finance the hedge against an eventual recovery.
• Pair trade: long MELI / short a Latin American e-commerce proxy with weaker scale economics, on the thesis that reinvestment will entrench MELI’s share while others cannot match promotions. Time horizon: 6-12 months; the trade works best if price competition intensifies.
• If you want exposure to the AI efficiency angle, stage entries only after evidence of operating leverage re-emerges; otherwise the market will continue to treat AI spending as cost inflation rather than margin expansion. The catalyst window is likely 2H26, not the next few weeks.
• Avoid chasing consensus downgrades into the print; the lower target revisions are already acknowledging the margin reset, so incremental downside now depends on whether Brazil economics worsen faster than expected. Monitor for stabilization in analyst EPS revisions as the signal to add risk.